MEDPLUS HEALTH SERVICES
|
MEDPLUS HEALTH SERVICES Last 5 Year Financial Ratios History
[Consolidated]
| Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
|---|---|---|---|---|---|
| Operational & Financial Ratios | |||||
| Earnings Per Share (Rs) | 5.48 | 4.17 | 8.03 | 1,425.40 | 92.47 |
| CEPS(Rs) | 24.24 | 19.42 | 17.94 | 675.81 | 350.98 |
| DPS(Rs) | - | - | - | - | - |
| Book NAV/Share(Rs) | 129.47 | 122.44 | 117.89 | 15,220.96 | 26,758.09 |
| Tax Rate(%) | 10.71 | -6.24 | 19.69 | 33.64 | 93.89 |
| Margin Ratios | |||||
| Core EBITDA Margin(%) | 6.51 | 6.08 | 7.54 | 7.32 | 4.65 |
| EBIT Margin(%) | 3.28 | 3.15 | 5.24 | 5.19 | 2.65 |
| Pre Tax Margin(%) | 1.29 | 1.02 | 3.08 | 3.04 | 1.02 |
| PAT Margin (%) | 1.15 | 1.08 | 2.47 | 2.01 | 0.06 |
| Cash Profit Margin (%) | 5.08 | 5.01 | 5.59 | 4.83 | 2.67 |
| Performance Ratios | |||||
| ROA(%) | 2.30 | 1.86 | 4.51 | 4.31 | 0.18 |
| ROE(%) | 4.36 | 3.50 | 9.07 | 10.51 | 0.43 |
| ROCE(%) | 12.19 | 9.56 | 16.56 | 21.69 | 14.34 |
| Asset Turnover(x) | 2.00 | 1.72 | 1.83 | 2.14 | 2.84 |
| Sales/Fixed Asset(x) | 3.28 | 3.39 | 4.13 | 4.38 | 6.76 |
| Working Capital/Sales(x) | 5.47 | 4.60 | 3.57 | 6.16 | 8.58 |
| Efficiency Ratios | |||||
| Fixed Capital/Sales(x) | 0.30 | 0.30 | 0.24 | 0.23 | 0.15 |
| Receivable days | 0.84 | 0.58 | 0.54 | 0.69 | 0.96 |
| Inventory Days | 79.52 | 81.27 | 79.28 | 81.18 | 65.93 |
| Payable days | 21.33 | 25.98 | 24.13 | 28.76 | 31.00 |
| Valuation Parameters | |||||
| PER(x) | 125.87 | 156.11 | 125.80 | - | - |
| PCE(x) | 28.44 | 33.53 | 56.30 | - | - |
| Price/Book(x) | 5.33 | 5.32 | 8.57 | - | - |
| Yield(%) | - | - | - | - | - |
| EV/Net Sales(x) | 1.44 | 1.64 | 3.22 | 0.01 | -0.01 |
| EV/Core EBITDA(x) | 19.69 | 22.86 | 37.97 | 0.07 | -0.23 |
| EV/EBIT(x) | 43.29 | 51.30 | 60.53 | 0.11 | -0.47 |
| EV/CE(x) | 5.13 | 5.02 | 4.63 | 0.01 | -0.03 |
| M Cap / Sales | 1.47 | 1.70 | 3.19 | - | - |
| Growth Ratio | |||||
| Net Sales Growth(%) | 23.42 | 20.59 | 23.13 | 6.92 | 26.31 |
| Core EBITDA Growth(%) | 25.61 | 2.25 | 27.71 | 66.11 | 126.54 |
| EBIT Growth(%) | 28.24 | -27.38 | 23.63 | 113.38 | 44.56 |
| PAT Growth(%) | 30.88 | -47.10 | 50.08 | 3,417.89 | -91.42 |
| EPS Growth(%) | 31.32 | -48.06 | -99.44 | 1,441.40 | -91.42 |
| Financial Stability Ratios | |||||
| Total Debt/Equity(x) | - | - | 0.10 | 0.20 | 0.20 |
| Current Ratio(x) | 2.98 | 3.11 | 2.92 | 2.14 | 1.67 |
| Quick Ratio(x) | 0.43 | 0.71 | 1.28 | 0.46 | 0.38 |
| Interest Cover(x) | 1.65 | 1.48 | 2.42 | 2.41 | 1.63 |
| Total Debt/Mcap(x) | - | - | 0.01 | - | - |
Compare Financial Ratios of peers of MEDPLUS HEALTH SERVICES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| MEDPLUS HEALTH SERVICES | ₹9,526.9 Cr | -4.8% | 8.9% | 21% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹418,648.0 Cr | -4.9% | 2.1% | 15.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹159,310.0 Cr | -2.2% | 9.3% | 50.5% | Stock Analytics | |
| CIPLA | ₹119,410.0 Cr | -4.2% | 4.5% | 4.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹106,189.0 Cr | -4.4% | -4.5% | 17.2% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹96,496.4 Cr | -1.4% | 4.2% | -8.8% | Stock Analytics | |
MEDPLUS HEALTH SERVICES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| MEDPLUS HEALTH SERVICES | -4.8% |
8.9% |
21% |
| SENSEX | -1.3% |
4.1% |
7.6% |
You may also like the below Video Courses
